Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina.

Liquidia Corporation

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Liquidia Technologies (LQDA), AbbVie (ABBV) and Esta...

Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA), AbbVie (ABBV) and Establishment Labs Holdings (ESTA)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid...

Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid (PYPD)

Liquidia Technologies ($LQDA) announced an update on their ongoing clinical study. The RE-WARM Phase 2a study, officially titled “A Phase 2a Random...

Liquidia Expands LIQ861 Into Raynaud’s: What the New RE-WARM Study Means for Investors

In a report released today, Gaurav Maini from LifeSci Capital maintained a Buy rating on Liquidia Technologies, with a price target of $101.00. Mai...

LifeSci Capital Sticks to Their Buy Rating for Liquidia Technologies (LQDA)

Insiders have been trading these 5 stocks: (($NRDY)), (($KC)), (($LQDA)), (($MRSH)) and (($VSXY)). Here is a breakdown of their recent trades and t...

CLO, Kingsoft, Liquidia, Marsh, Victoria’s Secret Sell-Offs

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on MindWalk Holdings (HYFT) and Liquidia Technologies (...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	LQDA	$77.70	+4.38%	1.52M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	LQDA	$77.70	+4.4%	1.52M
3
4
5
6

LQDA

Get Liquidia Corporation Data in Excel

Get Liquidia Corporation Data in Excel